Published October 29, 2023 | Version 231029
Preprint Open

Role of Bile Acid Pathway Intermediates in Pathology of CTX

Description

A deficiency in the enzyme sterol 27-hydroxylase (CYP27A1) leads to the autosomal recessive disorder cerebrotendinous xanthomatosis (CTX). CYP27A1 catalyses the first steps of the acidic pathway of bile acid biosynthesis. Most cells express CYP27A1, and a deficiency in this enzyme results in the activation of shunt pathways to help remove excess cholesterol. CYP27A1 also appears in the middle of the neutral pathway of bile acid biosynthesis and its deficiency results in accumulation of up-stream pathway intermediates. Here we describe methods for the simultaneous analysis of almost all metabolites from cholesterol to bile acids in a single assay and discuss the relative importance of accumulation of pathway intermediates and missing metabolites to the pathology of CTX.

Files

231029_Griffiths_CTX_with_Figures.pdf

Files (653.2 kB)

Name Size Download all
md5:e36ab0051e70ac3cb22e82b814eb003b
653.2 kB Preview Download

Additional details

Funding

Medical Research Council
Lipidomics and metabolomics for rare disease diagnosis MR/Y008057/1
Medical Research Council
Spatial Cholesterol Metabolism: A Mass Spectrometer for Better Diagnosis and Understanding of Disease MR/X012387/1
Biotechnology and Biological Sciences Research Council
An Integrated platform for Quantitative Sterolomics: From Oxysterols to Bile Acids and Steroids BB/I001735/1
Biotechnology and Biological Sciences Research Council
Mass Spectrometry Based Lipidomics and Metabolomics to Drive Bioscience Discovery BB/S019588/1
Biotechnology and Biological Sciences Research Council
Identification of endogenous ligands for the Retinoid-related Orphan Receptor gamma BB/L001942/1

Dates

Created
2023-10-29